141 related articles for article (PubMed ID: 33714670)
1. Prognostic significance of extracellular volume fraction with equilibrium contrast-enhanced computed tomography for pancreatic neuroendocrine neoplasms.
Iwaya H; Fukukura Y; Hashimoto S; Tanoue S; Kawahira M; Hinokuchi M; Fujita T; Komaki Y; Arima S; Sasaki F; Kanmura S; Higashi M; Tamada K; Ido A
Pancreatology; 2021 Jun; 21(4):779-786. PubMed ID: 33714670
[TBL] [Abstract][Full Text] [Related]
2. Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a prognostic factor in patients with stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1679-1689. PubMed ID: 31728691
[TBL] [Abstract][Full Text] [Related]
3. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
[TBL] [Abstract][Full Text] [Related]
4. Extracellular volume fraction determined by equilibrium contrast-enhanced multidetector computed tomography as a prognostic factor in unresectable pancreatic adenocarcinoma treated with chemotherapy.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Takumi K; Maemura K; Higashi M; Kamimura K; Nakajo M; Yoshiura T
Eur Radiol; 2019 Jan; 29(1):353-361. PubMed ID: 29922930
[TBL] [Abstract][Full Text] [Related]
5. Estimation of pancreatic fibrosis and prediction of postoperative pancreatic fistula using extracellular volume fraction in multiphasic contrast-enhanced CT.
Sofue K; Ueshima E; Masuda A; Shirakawa S; Zen Y; Ueno Y; Tsujita Y; Yamaguchi T; Yabe S; Tanaka T; Inomata N; Toyama H; Fukumoto T; Kodama Y; Murakami T
Eur Radiol; 2022 Mar; 32(3):1770-1780. PubMed ID: 34636963
[TBL] [Abstract][Full Text] [Related]
6. Extracellular volume fraction determined by equilibrium contrast-enhanced computed tomography: correlation with histopathological findings in gastric cancer.
Nishimuta Y; Tsurumaru D; Kai S; Maehara J; Asayama Y; Oki E; Ishigami K
Jpn J Radiol; 2023 Jul; 41(7):752-759. PubMed ID: 36735208
[TBL] [Abstract][Full Text] [Related]
7. Extracellular volume fraction derived from equilibrium contrast-enhanced CT as a diagnostic parameter in anterior mediastinal tumors.
Takumi K; Nagano H; Oose A; Gohara M; Kamimura K; Nakajo M; Harada-Takeda A; Ueda K; Tabata K; Yoshiura T
Eur J Radiol; 2023 Aug; 165():110891. PubMed ID: 37245341
[TBL] [Abstract][Full Text] [Related]
8. Visual enhancement pattern during the delayed phase of enhanced CT as an independent prognostic factor in stage IV pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nagano H; Hidaka S; Kamimura K; Maemura K; Arima S; Yoshiura T
Pancreatology; 2020 Sep; 20(6):1155-1163. PubMed ID: 32800574
[TBL] [Abstract][Full Text] [Related]
9. Extracellular volume fraction with MRI: As an alternative predictive biomarker to dynamic contrast-enhanced MRI for chemotherapy response of pancreatic ductal adenocarcinoma.
Fukukura Y; Kumagae Y; Fujisaki Y; Nakamura S; Dominik Nickel M; Imai H; Yoshiura T
Eur J Radiol; 2021 Dec; 145():110036. PubMed ID: 34814039
[TBL] [Abstract][Full Text] [Related]
10. Extracellular volume fraction determined by dual-layer spectral detector CT: Possible role in predicting the efficacy of preoperative neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma.
Fujita N; Ushijima Y; Itoyama M; Okamoto D; Ishimatsu K; Wada N; Takao S; Murayama R; Fujimori N; Nakata K; Nakamura M; Yamamoto T; Oda Y; Ishigami K
Eur J Radiol; 2023 May; 162():110756. PubMed ID: 36907069
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Predicting Role of Contrast-Enhanced Computed Tomography for Locally Advanced Pancreatic Adenocarcinoma.
Cheng CS; Liu W; Zhou L; Tang W; Zhong A; Meng Z; Chen L; Chen Z
Biomed Res Int; 2019; 2019():1356264. PubMed ID: 31886169
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of new subtraction algorithm in estimating degree of liver fibrosis by calculating extracellular volume fraction obtained from routine liver CT protocol equilibrium phase data: Preliminary experience.
Shinagawa Y; Sakamoto K; Sato K; Ito E; Urakawa H; Yoshimitsu K
Eur J Radiol; 2018 Jun; 103():99-104. PubMed ID: 29803393
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer.
Fukui H; Onishi H; Nakamoto A; Tsuboyama T; Ota T; Yano K; Enchi Y; Yamada D; Takeda Y; Kobayashi S; Fukuda Y; Eguchi H; Matsui T; Tatsumi M; Tomiyama N
Eur J Radiol; 2022 Nov; 156():110522. PubMed ID: 36113381
[TBL] [Abstract][Full Text] [Related]
14. Extracellular volume-based scoring system for tracking tumor progression in pancreatic cancer patients receiving intraoperative radiotherapy.
Cai W; Zhu Y; Teng Z; Li D; Cong R; Chen Z; Ma X; Zhao X
Insights Imaging; 2024 May; 15(1):116. PubMed ID: 38735009
[TBL] [Abstract][Full Text] [Related]
15. A Preliminary Pathological Evaluation of Extracellular Volume Fraction with Contrast-enhanced Computed Tomography as a Novel Quantitative Parameter of Pancreatic Fibrosis.
Kai K; Hiyoshi M; Imamura N; Hamada T; Yano K; Sato Y; Sakae T; Komi M; Nakamura T; Choijookhuu N; Hishikawa Y; Nanashima A
Intern Med; 2023; 62(8):1107-1115. PubMed ID: 37062714
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of volume-based FDG PET/CT parameters in patients with locally advanced pancreatic cancer treated with chemoradiation therapy.
Choi HJ; Lee JW; Kang B; Song SY; Lee JD; Lee JH
Yonsei Med J; 2014 Nov; 55(6):1498-506. PubMed ID: 25323885
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
Chirindel A; Alluri KC; Chaudhry MA; Wahl RL; Pawlik TM; Herman JM; Subramaniam RM
AJR Am J Roentgenol; 2015 May; 204(5):1093-9. PubMed ID: 25905947
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.
Park HJ; Kim HJ; Kim JH; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Eur Radiol; 2023 Apr; 33(4):2713-2724. PubMed ID: 36378252
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
Cai X; Gao F; Qi Y; Lan G; Zhang X; Ji R; Xu Y; Liu C; Shi Y
Eur Radiol; 2020 Sep; 30(9):5158-5169. PubMed ID: 32346792
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
